Abstract
Malignant fibrous histiocytoma (MFH) is the most frequent malignant soft tissue tumor in adults. A primary MFH occurs most commonly in the extremities and the trunk, but rarely in the pelvic cavity. We report a case of malignant fibrous histiocytoma of the unknown origin in the pelvic cavity with a review of the literature. The neoplasm occurred in the pelvic cavity of 53-year-old female who complained of enlarging nontender mass in the lower abdomen. The final diagnosis was based on the pathological report of the surgical specimen.
References
1. Kauffman SL, Stout AP. Histiocytic tumors (fibrous xanthoma and histiocytoma) in children. Cancer. 1961. 14:469–482.
2. Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft tissue sarcoma. Ann Surg. 1991. 214:2–10.
3. Ozello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytoma and fibrous xanthoma. Cancer. 1963. 16:331–344.
4. O'Brien JE, Stout AP. Malignant fibrous xanthoma. Cancer. 1964. 17:1445–1455.
5. Kempson RL, Kyriakos M. Fibroxanthosarcoma of the soft tissues; A type of malignant fibrous histiocytoma. Cancer. 1972. 29:961–976.
6. Randall RL, Albritton KH, Ferney BJ, Layfield L. Malignant fibrous histiocytoma of soft tissue: An abandoned diagnosis. Am J Orthopedics. 2004. 33:602–608.
7. Mairal A, Terrier P, Chibon F, Sastre X, Lecesne A, Aurias A. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytoma. A comparative genomic hybridization analysis of a series of 30 cases. Cancer Genet Cytogenet. 1999. 111:134–138.
8. Pezzi CM, Rawlings MS Jr, Esgro JJ, Pollock RE, Romsdahl MM. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer. 1992. 69:2098–2103.
9. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: An analysis of 200 cases. Cancer. 1978. 41:2250–2266.
10. Gibbs JF, Huang PP, Lee RJ, McGrath B, Brooks J, McKinley B, et al. Malignant fibrous histiocytoma, an institutional review. Cancer Investigation. 2001. 19:23–27.
11. Jonathan JL, Murray EB. Soft tissue sarcoma. Curr Probl Surg. 1996. 33:821–863.
12. Belal A, Kandil A, Allam A, Khafaga Y, El-Husseinv G, El-Enbabv A, et al. Malignant fibrous histiocytoma: A retrospective study of 109 cases. Am J Clin Oncol. 2002. 25:16–22.
13. Lindberg RD, Martin RG, Romsdahl MM, Barkley HT Jr. Conservative surgery and post operative radiotherapy in 300 adults with soft tissue sarcoma. Cancer. 1981. 47:2391–2397.
14. Blitzer A, Lawson W, Zak FG, Biller HF, Som ML. Clinical-pathological determinants in prognosis of fibrous histiocytoma of the head and neck. Laryngoscope. 1981. 91:2053–2070.
15. Mcgrath PC, Neifeld JP, Lawrence W Jr, DeMay RM, Kay S, Horsley JS 3rd, et al. Improved survival following complete excision of retroperitoneal sarcomas. Ann Surg. 1984. 200:200–204.
16. Leite C, Goodwin JW, Sinkovics JG, Baker LH, Benjamen R. Chemotherapy of malignant fibrous histiocytoma. A Southwest Oncology Group Report. Cancer. 1997. 40:2010–2014.
17. Patel SR, Plaqer C, Papadopoulos NE, Benjamin RS. Myxoid malignant fibrous histiocytoma: Experience with chemotherapy. Am J Clin Oncol. 1995. 8:528–531.